Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Rallybio Corp

NASDAQ: RLYB · Life Sciences · 6 alerts · CIK 1739410

Share price
$15.43Close, Nov 16
Market cap
$83M
Shares outstanding
5.38MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Rallybio Corp filings on SEC EDGAR ↗

5:21 PM ET 8-K
Reverse Stock Split

Rallybio Reverse Stock Split

Rallybio announced a 1-for-2 reverse stock split effective November 20, 2026, reducing outstanding shares from 5.6 million to 2.8 million. The split is being executed in connection with its pending merger with Avenzo Therapeutics, Inc., after which the combined company will trade under the symbol AVZO. The final ratio was mutually determined by both companies following shareholder approval at the November 4, 2026, annual meeting.

Counterparty
Avenzo Therapeutics, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.